What is Cumberland Pharmaceuticals's equity method income?

Cumberland Pharmaceuticals (CPIX) reported equity method income of -$146.08K in Q1 2026.

What does equity method income mean?

The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.

Cumberland Pharmaceuticals CPIX Equity Method Income

Equity Method Income at other companies

BridgeBio PharmaBBIO

-$18.28M-17.5%

Opko HealthOPK

-$2K+77.8%

West Pharmaceutical ServicesWST

$3.4M0.0%

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's equity method income?: Cumberland Pharmaceuticals (CPIX) reported equity method income of -$146.08K in Q1 2026.
What does equity method income mean?: The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.